Pyxis Oncology PYXS
NASDAQ PYXS
$1.68 -0.03 (-1.75%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) Non Operating Investment Income (2023 - 2026)

Updated

Pyxis Oncology's Non Operating Investment Income came in at -$4,000 for Q2 2026, compared with -$54,000 a year earlier.

Analysis

Pyxis Oncology (PYXS) Non Operating Investment Income (2023 - 2026) Analysis & Trends

For FY2025, Pyxis Oncology's Non Operating Investment Income was -$117,000.

  • Going back by year, Non Operating Investment Income was $107,000 in FY2024 (+69.8%) and $63,000 in FY2023.
  • The five-year range for quarterly Non Operating Investment Income is -$781,000 (Q2 2023) to $696,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Pyxis Oncology 106.57 Mn -158.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,000.00
Dec 31, 2025 -16,000.00
Sep 30, 2025 74,000.00
Jun 30, 2025 -54,000.00
Mar 31, 2025 -121,000.00
Dec 31, 2024 -181,000.00
Sep 30, 2024 453,000.00
Jun 30, 2024 -42,000.00
Mar 31, 2024 -123,000.00
Dec 31, 2023 168,000.00
Sep 30, 2023 -20,000.00
Jun 30, 2023 -781,000.00
Mar 31, 2023 696,000.00
API Access

Pyxis Oncology Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PYXS&period=max&api_key=YOUR_API_KEY